Tiffany Ferris

Practices

Industries

Education and Clerkships

J.D., William & Mary Law School, 2013, cum laude

B.S.B.A., Marketing, University of Richmond, 2010, magna cum laude

B.A., Religion, University of Richmond, 2010, magna cum laude

Admissions

Texas, 2013

Profile

Tiffany Ferris assists clients in all aspects of brand management and promotion. From evaluating the availability of a potential trademark to analyzing potential risks associated with advertising claims, Tiffany works to help her clients build, maintain, and promote their brands.

Tiffany has supported clients through all stages of their brand's lifecycle, including procuring trademark and copyright registrations, reviewing national advertising materials, and enforcing her clients’ copyright and trademark rights in the United States and abroad. She has participated in litigation before the U.S. Trademark Trial and Appeal Board, and is adept at managing complex international trademark opposition and cancellation proceedings. Her experience extends to internet-related subjects like domain name cybersquatting and social media use. She also counsels clients regarding emerging intellectual property issues, like those raised by the digital reproduction and use of images and objects.

Tiffany also supports clients in the design and development of product packaging and labeling. She counsels clients on the intellectual property implications of label design, and provides guidance regarding compliance with FDA and FTC regulations. She is adept at recognizing the message a client wishes to convey and providing practical, business-minded guidance on structuring advertising and marketing materials to both promote that message and manage risk appropriately. Not just a counselor, Tiffany also represents her clients in proceedings before the National Advertising Division (NAD).

No matter the topic at hand, Tiffany is mindful of her clients’ overarching goals and business concerns. She has considerable practical experience with product and packaging development, marketing, and manufacturing, gained from her previous work with Reynolds Packaging Group, formerly a division of Alcoa. Tiffany’s keen understanding of business and marketing practices allows her to develop creative strategies for managing and promoting her clients’ brands.

When not working on behalf of her clients, Tiffany participates in animal welfare initiatives in the Dallas area. A life-long dog lover, Tiffany is a member of the Animal Welfare Committee of the Dallas Association of Young Lawyers.

Intellectual Property

IP Beacon Year in Review 2018

The Intellectual Property Law 2018 Year In Review

We are pleased to highlight some of our representative intellectual property-related client successes and publications over the past year that might be relevant to your business success in the coming year. We represented clients in 74 inter partes review/PTAB proceedings that were filed in 2018, and our patent prosecution team filed over 2,300 U.S. patent applications and helped issue more than 1,650 U.S. patents just in 2018. We also helped close the IP issues in dozens of financings, M&A transactions, and joint venture/licensing arrangements.
Trigg, Hampton and Ferris

FDLI Update: What’s in a Name? Sometimes, a Claim

Haynes and Boone Partner Suzie Trigg, Senior Counsel Phil Hampton II, and Associate Tiffany Ferris write in FDLI’s Update on trademark compliance with Food and Drug Administration rules.

Professional and Community Activities

  • Board of Directors, Children's Chorus of Greater Dallas, 2019
  • State Bar of Texas
  • Dallas Bar Association
  • William & Mary Law School Alumni Ambassadors Program
  • Dallas Association of Young Lawyers, Animal Welfare Committee

Newsletter

Health Law Vitals

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone

The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses the fiduciary duties of directors in medical technology, the promises and pitfalls of telehealth, the FDA's expansion of the Abbreviated 510(k) pathway, and more.

Email Disclaimer